Skip to main navigation Skip to search Skip to main content

Comparison of Study Drug: A Protocol Biopsy Directed Approach CERL080A-US59

Project: Research

Project Details

StatusFinished
Effective start/end date01/11/0805/31/15

Funding

  • Novartis Pharmaceuticals Corporation: $569,344.52